FDA rolls out more guidance on 'N of 1' gene therapies
Regulatory NewsKari Oakes
Biologics/ biosimilars/ vaccinesClinical TrialsHealth Authority meeting and communication strategyNorth AmericaPreclinical studyQuality Assurance and ControlRegulatory NewsKari OakesBiologics/ biosimilars/ vaccinesClinical TrialsHealth Authority meeting and communication strategyNorth AmericaPreclinical studyQuality Assurance and Control